GlassScriptPhysician profile
John F Simmons
NPI 1942452123
$3,266.15
in general payments reported to CMS, 2019-2025
31 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $656 · 2021: $697 · 2022: $363 · 2023: $660 · 2024: $373 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.02 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $671.62 | 2021-2025 | Vraylar |
| Lilly USA, LLC | $398.86 | 2019-2023 | Mounjaro, Trulicity |
| Avanir Pharmaceuticals, INC. | $240.60 | 2020-2022 | |
| Novo Nordisk INC | $168.97 | 2020-2021 | |
| Glaxosmithkline, LLC. | $168.62 | 2022-2024 | Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $143.82 | 2020-2024 | Breztri, Airsupra |
| Allergan, INC. | $119.17 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $118.49 | 2020-2024 | Rexulti, Nuedexta |
| Shockwave Medical, INC | $99.44 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $98.00 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $93.10 | 2023 | Quviviq |
| Pfizer INC. | $90.90 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $89.28 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $85.81 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $75.96 | 2025 | Caplyta |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $70.80 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.61 | 2020-2025 | Jardiance |
| Amgen INC. | $61.55 | 2019-2024 | Evenity, Prolia |
| Eisai INC. | $56.27 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $51.09 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $51.00 | 2024-2025 | Gemtesa |
| Lundbeck LLC | $39.46 | 2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $38.33 | 2019 | |
| Amarin Pharma, INC. | $37.63 | 2021 | |
| Exact Sciences Corporation | $28.89 | 2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $19.72 | 2023 | |
| Abbott Laboratories | $18.90 | 2024 | Freestyle Libre 3 |
| Bioventus LLC | $17.71 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.20 | 2023 | Trulance, Xifaxan |
| Averitas Pharma INC. | $16.27 | 2025 | Qutenza |
| Athena Bioscience, LLC | $9.08 | 2023 | Qdolo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.